| Section | Status | CDF | Name |
| 08.03.04.02 | Restricted Use |  |
Abiraterone Zytiga® |
| 08.01.05 | Restricted Use | |
Aflibercept Zaltrap® |
| 08.01.01 | Restricted Use | |
Bendamustine |
| 08.02.03 | Restricted Use | |
Bevacizumab Avastin® |
| 08.01.05 | Restricted Use | |
Bortezomib Velcade® |
| 08.01.05 | Restricted Use | |
Bosutinib Bosulif® |
| 08.01.05 | Restricted Use | |
Brentuximab vedotin Adcetris® |
| 08.01.05 | Restricted Use | |
Cabazitaxel Jevtana® |
| 08.01.05 | Restricted Use | |
Cabozantinib Cometriq® |
| 08.01.05 | Restricted Use | |
Cemiplimab Libtayo® |
| 08.01.05 | Restricted Use | |
Cetuximab Erbitux® |
| 08.01.03 | Restricted Use | |
Clofarabine Evoltra® |
| 08.01.05 | Restricted Use | |
Crizotinib Xalkori® |
| 08.01.05 | Restricted Use | |
Dabrafenib Tafinlar® |
| 08.01.05 | Restricted Use | |
Dasatinib Sprycel® |
| 08.01.02 | Restricted Use | |
Doxorubicin Hydrochloride (Lipid formulation) Caelyx® |
| 08.02.03 | Restricted Use | |
Durvalumab Imfinzi® |
| 08.01.05 | Restricted Use | |
Eribulin Halaven® |
| 08.01.05 | Restricted Use | |
Everolimus Afinitor® |
| 08.01.05 | Restricted Use | |
Idelalisib Zydelig® |
| 08.01.05 | Restricted Use | |
Ipilimumab Yervoy® |
| 08.02.04 | Restricted Use | |
Lenalidomide Revlimid® |
| 08.01.03 | Restricted Use | |
Nelarabine Atriance® |
| 08.02.03 | Restricted Use | |
Obinutuzumab Gazyvaro ® |
| 08.01.05 | Restricted Use | |
Olaparib Lynparza® |
| 08.01.05 | Restricted Use | |
Palbociclib Ibrance® |
| 08.01.05 | Non Formulary | |
Panitumumab Vectibix® |
| 08.01.05 | Restricted Use | |
Pembrolizumab Keytruda® |
| 08.01.03 | Restricted Use | |
Pemetrexed Alimta® |
| 08.01.05 | Restricted Use | |
Pertuzumab Perjeta® |
| 08.02.04 | Restricted Use | |
Pomalidomide Imnovid® |
| 08.01.05 | Restricted Use | |
Ponatinib Iclusig® |
| 08.01.05 | Restricted Use | |
Regorafenib Stivarga® |
| 08.01.05 | Restricted Use | |
Ribociclib Kisqali® |
| 08.01.05 | Restricted Use | |
Rucaparib Rubraca® |
| 08.01.05 | Restricted Use | |
Ruxolitinib Jakavi® |
| 08.01.05 | Restricted Use | |
Sorafenib Nexavar® |
| 08.01.05 | Restricted Use | |
Sunitinib Sutent® |
| 08.01.05 | Restricted Use | |
Temsirolimus Torisel® |
| 08.01.05 | Restricted Use | |
Tisagenlecleucel Kymriah® |
| 08.01.05 | Non Formulary | |
Vandetanib Caprelsa® |
| 08.01.05 | Restricted Use | |
Venetoclax Venclyxto® |
| 08.01.05 | Restricted Use | |
Vismodegib Erivedge® |